We are live on
!
Find out more
Anavex Life Sciences
AVXL
AVXL
143 hedge funds and large institutions have $164M invested in Anavex Life Sciences in 2023 Q3 according to their latest regulatory filings, with 13 funds opening new positions, 53 increasing their positions, 46 reducing their positions, and 14 closing their positions.
New
Increased
Maintained
Reduced
Closed
37% more call options, than puts
Call options by funds: $12.8M | Put options by funds: $9.34M
15% more repeat investments, than reductions
Existing positions increased: 53 | Existing positions reduced: 46
1% less funds holding
Funds holding: 144 → 143 (-1)
0.69% less ownership
Funds ownership: 31.27% → 30.58% (-0.69%)
7% less first-time investments, than exits
New positions opened: 13 | Existing positions closed: 14
20% less capital invested
Capital invested by funds: $206M → $164M (-$41.5M)
Holders
143
Holders Change
-1
Holders Change %
-0.69%
% of All Funds
2.27%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
13
Increased
53
Reduced
46
Closed
14
Calls
$12.8M
Puts
$9.34M
Net Calls
+$3.44M
Net Calls Change
-$333K
Top Buyers
| 1 |
Citadel Advisors
Miami,
Florida
|
+$4.23M |
| 2 |
Millennium Management
New York
|
+$3.78M |
| 3 |
SG Americas Securities
New York
|
+$2.14M |
| 4 |
Marshall Wace
London,
United Kingdom
|
+$1.15M |
| 5 |
BlackRock
New York
|
+$973K |
Top Sellers
| 1 |
State Street
Boston,
Massachusetts
|
-$6.24M |
| 2 |
Jane Street
New York
|
-$2.8M |
| 3 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$1.49M |
| 4 |
Qube Research & Technologies (QRT)
London,
United Kingdom
|
-$1.4M |
| 5 |
Goldman Sachs
New York
|
-$789K |
